 |
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide |
|---|---|
| Trade Name | Yeliva |
| Orphan Indication | Bile duct cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-30 00:00:00 |
| Sponsor | RedHill Biopharma Ltd.;21 Ha'arba'a Street;Tel Aviv-Yafo |
| |
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide |
|---|---|
| Trade Name | Yeliva |
| Orphan Indication | Bile duct cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-30 00:00:00 |
| Sponsor | RedHill Biopharma Ltd.;21 Ha'arba'a Street;Tel Aviv-Yafo |